NOTICE TO DISREGARD — Bright Meds



NOTICE TO DISREGARD — Bright Meds

GlobeNewswire

February 04, 2026


NEW YORK, January, Feb. 04, 2026 (GLOBE NEWSWIRE) — We are advised by Bright Meds that journalists and other readers should disregard the news release, “Brightmeds Tirzepatide Investigated: Is It Safe and Legit for Weight Loss? Exploring Safety, Side Effects, and Results (2026 Analysis)” issued January 21, 2026, 10:06 ET, over GlobeNewswire.



Scroll to Top